Triptorelin acetate | CAS:140194-24-7

We serve Triptorelin acetate CAS:140194-24-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Triptorelin acetate

Chemical Name:Triptorelin acetate
CAS.NO:140194-24-7
Synonyms:Triptorelin acetate
 
Physical and Chemical Properties:
Density 1.52g/cm3
Molecular Formula C66H86N18O15
Molecular Weight 1371.501
Index of Refraction 1.723
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Triptorelin acetate is a potent LHRH agonist. It can result in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis. For most prostate cancers, they need the hormone testosterone in order to grow. Almost all testosterone in men is made by the testicles. Triptorelin stops the testicles from making testosterone. This reduces testosterone levels and may shrink the prostate cancer or stop it growing.



Contact us for information like Triptorelin acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Triptorelin acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Triptorelin acetate Use and application,Triptorelin acetate technical grade,usp/ep/jp grade.


Related News: Over the past few days, there’s been a question dominating Chinese social media: Could a traditional Chinese medicine help fight the Wuhan coronavirus?Arbutin manufacturer Over the past few days, there’s been a question dominating Chinese social media: Could a traditional Chinese medicine help fight the Wuhan coronavirus?4-Aminophenol sulfate supplier ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.Dibenzofuran-4-Boronic Acid vendor ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.Professor Coleman was involved in some of the first research into MERS in the US.